Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016885
Filing Date
2019-11-12
Accepted
2019-11-12 16:01:07
Documents
48
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 380212
2 ex31-1.htm EX-31.1 19139
3 ex31-2.htm EX-31.2 19122
4 ex32-1.htm EX-32.1 7987
5 ex32-2.htm EX-32.2 8058
  Complete submission text file 0001493152-19-016885.txt   2553017

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE codx-20190930.xml EX-101.INS 349043
7 XBRL SCHEMA FILE codx-20190930.xsd EX-101.SCH 37394
8 XBRL CALCULATION FILE codx-20190930_cal.xml EX-101.CAL 41436
9 XBRL DEFINITION FILE codx-20190930_def.xml EX-101.DEF 119664
10 XBRL LABEL FILE codx-20190930_lab.xml EX-101.LAB 296693
11 XBRL PRESENTATION FILE codx-20190930_pre.xml EX-101.PRE 203580
Mailing Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124
Business Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124 8012789769
Co-Diagnostics, Inc. (Filer) CIK: 0001692415 (see all company filings)

EIN.: 462609396 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38148 | Film No.: 191209167
SIC: 3841 Surgical & Medical Instruments & Apparatus